Fundraising Fox
Actio Biosciences, Inc.
Founded 2021 · 47 employees on LinkedIn · 3 known investors
Find your way into Actio Biosciences, Inc.
Sign up to see every warm intro you have to Actio Biosciences, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Actio Biosciences, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
Founders & leadership
Actio Biosciences, Inc. was founded in 2021 by David Breckenridge.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Actio Biosciences, Inc. do?
- Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
- Who founded Actio Biosciences, Inc.?
- Actio Biosciences, Inc. was founded by David Breckenridge in 2021.
- Who are Actio Biosciences, Inc.'s investors?
- Actio Biosciences, Inc.'s investors include Canaan Partners, EcoR1 Capital, Droia Ventures.